Ledger.Open graph →
SEC Form D · Amendment · filed September 18, 2018

Fountain Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Francisco, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Ken Tapp · Englewood, COExec · Director · PromoterAdam Sanchez · San Antonio, TXExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗